The lack of immunogenicity has practical implications: the peptide can be used for extended periods without loss of efficacy due to antibody neutralization, there is minimal risk of allergic or hypersensitivity reactions, and repeated treatment cycles are supported as prior exposure does not sensitize the immune system
FDA approval: AOD 9604 is not approved for any indication
In conclusion, AOD 9604 is a peptide that has been studied for its potential benefits in weight management and fat reduction
Peptides Tested For More Than Just Purity We conduct an array of tests via HPLC and other methods for our peptides: purity, weight, endotoxins(LPS), sterility (bacteria & mold/yeast), and TFA content
The next step is maintenance dosing, which well cover next
This statement, published in the peer-reviewed Journal of Endocrinology and Metabolism, represents the consensus finding across all six trials and nearly 900 participants